A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

RecruitingOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

July 9, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Gastrointestinal Stromal TumorsUnresectable Solid TumorRecurrent Metastatic Malignant Neoplasm
Trial Locations (1)

510080

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

Fudan University

OTHER

collaborator

Peking University People's Hospital

OTHER

collaborator

Chinese PLA General Hospital

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Peking University Shenzhen Hospital

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

West China Hospital

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

Xijing Hospital

OTHER

collaborator

Shengjing Hospital

OTHER

collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Liaoning Cancer Hospital & Institute

OTHER

collaborator

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

collaborator

Fujian Medical University Union Hospital

OTHER

collaborator

Cancer Hospital of Guangxi Medical University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Chongqing University Cancer Hospital

OTHER

lead

Xinhua Zhang, MD

OTHER